# A Study to Evaluate the Safety and Clinical Efficacy of STR-P004

> **NCT07003178** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Starna Therapeutics** · enrollment: 30 (estimated)

## Conditions studied

- Non Hodgkin Lymphoma

## Interventions

- **DRUG:** STR-P004

## Key facts

- **NCT ID:** NCT07003178
- **Lead sponsor:** Starna Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06
- **Primary completion:** 2026-04
- **Final completion:** 2027-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07003178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07003178, "A Study to Evaluate the Safety and Clinical Efficacy of STR-P004". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07003178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*